Drug Profile


Alternative Names: CGP 48664; CGP 48664A; SAM 486

Latest Information Update: 15 Jun 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novartis
  • Class Amidines; Antineoplastics; Indans
  • Mechanism of Action Adenosylmethionine decarboxylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Non-Hodgkin's lymphoma; Solid tumours

Most Recent Events

  • 06 May 2004 A study has been added to the adverse events and Cancer therapeutic trials sections
  • 27 Sep 2000 Phase-II clinical trials for Non-Hodgkin's lymphoma in USA (IV-infusion)
  • 27 Sep 2000 A phase II study in non-Hodgkin's lymphoma has been added to the therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top